
Conference Coverage
Latest Content

Shorts










Videos
All News

An expert from Case Western Reserve University explains how cancer cells survive treatment, why rare diseases are hard to study and why CAR-T therapy offers hope.

The FDA approved Wilserdly with everolimus for some ER-positive, HER2-negative, ESR1-mutated advanced breast cancers that grew after prior hormone therapy.

An updated ASTRO guideline released Oct. 27, 2026, says most men getting radiation for prostate cancer that has not spread can safely finish treatment in weeks instead of months, and many can finish in five sessions. Here is what that means for patients.

Food safety, germs, fatigue, taste changes and tough questions can make Thanksgiving harder during cancer treatment. Here are five ways to plan ahead.

City of Hope experts share integrative therapies that may ease breast cancer side effects such as joint pain, hot flashes, poor sleep, fatigue and anxiety.

In a secondary analysis of a phase 3 trial published Nov. 13, 2026, people with locally advanced pancreatic cancer who wore the Optune Pax device with chemotherapy went about three months longer before their pain worsened than those who had chemotherapy alone.

City of Hope experts explain integrative oncology in breast cancer: when to consider it, why it won't replace treatment and what to know about supplements.

Treatment for stomach cancer depends mostly on its stage and, for advanced disease, on biomarkers such as HER2. This Stomach Cancer Awareness Month explainer walks through the main options at each stage, based on National Cancer Institute guidance.

A mother whose daughter is seven years past breast cancer treatment shares how scan anxiety and waiting shape life after cancer for survivors and families.

A review of 29 studies in more than 22,000 women 65 and older with ER-positive breast cancer found no statistically significant survival difference between hormone therapy alone and surgery first, though surgery controlled the cancer in the breast better.

The FDA approved Imfinzi plus Padcev before and after surgery for adults with muscle-invasive bladder cancer who cannot or will not receive cisplatin.

Anxiety before a scan and while waiting for results is common for people with cancer and survivors. These five steps, drawn from ASCO, the American Cancer Society and the National Cancer Institute, can make the wait easier.

For Lung Cancer Awareness Month, five numbers from federal and American Cancer Society data show how survival for people with lung cancer has changed, how it differs by stage and type, and how many people are living with the disease.

A 12-year breast cancer survivor with 16 tattoos, including radiation marks, weighs new research on tattoos and lymphoma risk and the questions it prompts.

An Ohio State hematologist discusses a new trial comparing tovorafenib plus rituximab with standard cladribine-based treatment, and what quality of life means for patients.




































